Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.

By analogy with combination chemotherapy, endocrine agents with different mechanisms of action have been combined in the treatment of patients with advanced breast cancer. The clinical use of tamoxifen+aminoglutethimide+hydrocortisone showed no clinical benefit over the individual use of tamoxifen o...

Full description

Saved in:
Bibliographic Details
Main Authors: Dowsett, M., Harris, A. L., Smith, I. E., Jeffcoate, S. L.
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 1984
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1976801/
https://ncbi.nlm.nih.gov/pubmed/6540595
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items